These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35095075)

  • 41. Ivabradine treatment prevents dobutamine-induced increase in heart rate in patients with acute decompensated heart failure.
    Cavusoglu Y; Mert U; Nadir A; Mutlu F; Morrad B; Ulus T
    J Cardiovasc Med (Hagerstown); 2015 Sep; 16(9):603-9. PubMed ID: 24922198
    [TBL] [Abstract][Full Text] [Related]  

  • 42. I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.
    Abdel-Salam Z; Rayan M; Saleh A; Abdel-Barr MG; Hussain M; Nammas W
    Cardiol J; 2015; 22(2):227-32. PubMed ID: 25179314
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic significance of resting heart rate in atrial fibrillation patients with heart failure with reduced ejection fraction.
    Suzuki S; Motoki H; Kanzaki Y; Maruyama T; Hashizume N; Kozuka A; Yahikozawa K; Kuwahara K
    Heart Vessels; 2020 Aug; 35(8):1109-1115. PubMed ID: 32144498
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insufficient reduction in heart rate during hospitalization despite beta-blocker treatment in acute decompensated heart failure: insights from the ASCEND-HF trial.
    Kitai T; Grodin JL; Mentz RJ; Hernandez AF; Butler J; Metra M; McMurray JJ; Armstrong PW; Starling RC; O'Connor CM; Swedberg K; Tang WH
    Eur J Heart Fail; 2017 Feb; 19(2):241-249. PubMed ID: 27634557
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Review of New Pharmacologic Treatments for Patients With Chronic Heart Failure With Reduced Ejection Fraction.
    Nguyen E; Weeda ER; White CM
    J Clin Pharmacol; 2016 Aug; 56(8):936-47. PubMed ID: 26626162
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Different Impact of Changes in Left Ventricular Ejection Fraction Between Heart Failure Classifications in Patients With Acute Decompensated Heart Failure.
    Yamamoto M; Seo Y; Ishizu T; Nishi I; Hamada-Harimura Y; Machino-Ohtsuka T; Sato K; Sai S; Nakatsukasa T; Sugano A; Baba M; Obara K; Aonuma K; Ieda M
    Circ J; 2019 Feb; 83(3):584-594. PubMed ID: 30674752
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heart rate and its reduction in chronic heart failure and beyond.
    Nikolovska Vukadinović A; Vukadinović D; Borer J; Cowie M; Komajda M; Lainscak M; Swedberg K; Böhm M
    Eur J Heart Fail; 2017 Oct; 19(10):1230-1241. PubMed ID: 28627045
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sustained-Release Ivabradine Hemisulfate in Patients With Systolic Heart Failure.
    Ye F; Wang X; Wu S; Ma S; Zhang Y; Liu G; Liu K; Yang Z; Pang X; Xue L; Lu S; Zhong M; Li J; Yu H; Lou D; Cui D; Xie X; Wang J;
    J Am Coll Cardiol; 2022 Aug; 80(6):584-594. PubMed ID: 35926931
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ivabradine, a novel medication for treatment of heart failure with reduced ejection fraction.
    Foster JL; Bobadilla RV
    J Am Assoc Nurse Pract; 2016 Nov; 28(11):576-582. PubMed ID: 27215699
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Refining the prognostic impact of functional mitral regurgitation in chronic heart failure.
    Goliasch G; Bartko PE; Pavo N; Neuhold S; Wurm R; Mascherbauer J; Lang IM; Strunk G; Hülsmann M
    Eur Heart J; 2018 Jan; 39(1):39-46. PubMed ID: 29020337
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical Experience with Ivabradine in Acute Heart Failure.
    Pascual Izco M; Alonso Salinas GL; Sanmartín Fernández M; Del Castillo Carnevalli H; Jiménez Mena M; Camino López A; Zamorano Gómez JL
    Cardiology; 2016; 134(3):372-4. PubMed ID: 27100325
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Implications of Doppler Echocardiography-guided Heart Rate Modulation Using Ivabradine.
    Hori M; Imamura T; Narang N; Kinugawa K
    Intern Med; 2021 Dec; 60(24):3873-3877. PubMed ID: 34148961
    [TBL] [Abstract][Full Text] [Related]  

  • 53. β-Blockade in Heart Failure With Reduced Ejection Fraction: Does Heart Rate Control Influence Readmissions?
    Owens RE; Twilla JD; Self TH; Alshaya AI; Metra CJ; Cummings C; Oliphant CS
    J Pharm Pract; 2018 Feb; 31(1):40-45. PubMed ID: 28737066
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of ivabradine on left ventricular diastolic function of patients with heart failure with preserved ejection fraction -IVA-PEF study.
    Tanaka H; Yamauchi Y; Imanishi J; Hatani Y; Hayashi T; Hirata KI
    J Cardiol; 2021 Jun; 77(6):641-644. PubMed ID: 33390289
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
    Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The implication of optimal heart rate in patients with systolic dysfunction following TAVR.
    Imamura T; Tanaka S; Ushijima R; Sobajima M; Fukuda N; Ueno H; Besser S; Kinugawa K
    J Card Surg; 2021 Apr; 36(4):1328-1333. PubMed ID: 33538004
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Optimal Heart Rate and Prognosis in Patients with Cardiac Amyloidosis.
    Izumida T; Imamura T; Nakamura M; Kinugawa K
    J Cardiovasc Dev Dis; 2021 Dec; 8(12):. PubMed ID: 34940536
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of Ivabradine on Cardiac Remodeling in Patients With Stable Symptomatic Heart Failure: A Systematic Review and Meta-analysis.
    Wan H; Huang T; Zhang H; Wu Q
    Clin Ther; 2020 Dec; 42(12):2289-2297.e0. PubMed ID: 33160681
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of ivabradine therapy on heart failure biomarkers.
    Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H
    Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus.
    Kato ET; Silverman MG; Mosenzon O; Zelniker TA; Cahn A; Furtado RHM; Kuder J; Murphy SA; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Bonaca MP; Ruff CT; Desai AS; Goto S; Johansson PA; Gause-Nilsson I; Johanson P; Langkilde AM; Raz I; Sabatine MS; Wiviott SD
    Circulation; 2019 May; 139(22):2528-2536. PubMed ID: 30882238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.